A new oncology company spun out of Johns Hopkins School of Medicine is raising up to $40.5 million to develop its platform of anticancer therapies.
{iframe}https://endpts.com/startup-with-johns-hopkins-roots-raising-40-5-million-to-develop-cancer-metabolism-drugs/{/iframe}